Scotland retains neurosurgery network as foundation for new strategy
This article was originally published in Clinica
Scotland today announced that its four neurosurgery centres are to be retained as the basis of a strategy to modernise the service. Present arrangements for paediatric neurosurgery services, in particular, will be maintained at the Aberdeen, Dundee, Edinburgh and Glasgow centres, the Scottish Executive has highlighted. The decision is in line with the recommendations of the group set up in 2006 to advise the government on the development of a "managed service network". The Neuroscience Implementation Group is to remain active for an extra six months, with a view to developing a national service model.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.